Software Healthcare Sector

Teleflex

Market Cap: US$6.0b

Designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally.

Belite Bio

Market Cap: US$5.9b

A clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States.

BillionToOne

Market Cap: US$5.8b

A precision diagnostics company, quantifies biology to create molecular diagnostics.

Bausch + Lomb

Market Cap: US$5.8b

Operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally.

Erasca

Market Cap: US$5.8b

A clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

Twist Bioscience

Market Cap: US$5.6b

Manufactures and sells synthetic DNA-based products.

Convatec Group

Market Cap: UK£4.2b

Engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally.

Cochlear

Market Cap: AU$8.0b

Provides implantable hearing solutions for children and adults worldwide.

Amneal Pharmaceuticals

Market Cap: US$5.4b

A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally.

10x Genomics

Market Cap: US$5.4b

Develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific.

Stevanato Group

Market Cap: US$5.3b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Dianthus Therapeutics

Market Cap: US$5.3b

A clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases.

Chartwell Retirement Residences

Market Cap: CA$7.5b

Chartwell Retirement Residences is in the business of serving and caring for Canada’s seniors, committed to its vision of Making People’s Lives BETTER and to providing a happier, healthier, and more fulfilling life experience for its residents.

Travere Therapeutics

Market Cap: US$5.3b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

CRISPR Therapeutics

Market Cap: US$5.3b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Sotera Health

Market Cap: US$5.3b

Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

Celcuity

Market Cap: US$5.2b

A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.

Legend Biotech

Market Cap: US$5.2b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Oruka Therapeutics

Market Cap: US$5.2b

A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.

RadNet

Market Cap: US$5.2b

Provides outpatient diagnostic imaging services in the United States and internationally.

Veradermics

Market Cap: US$5.0b

A clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions.

Indivior Pharmaceuticals

Market Cap: US$4.9b

Engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Edgewise Therapeutics

Market Cap: US$4.9b

A biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.

Kiniksa Pharmaceuticals International

Market Cap: US$4.9b

A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.

Caris Life Sciences

Market Cap: US$4.8b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

Veracyte

Market Cap: US$4.5b

Operates as a diagnostics company in the United States and internationally.

LivaNova

Market Cap: US$4.5b

A medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally.

Viking Therapeutics

Market Cap: US$4.5b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

Tango Therapeutics

Market Cap: US$4.5b

A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.

ACADIA Pharmaceuticals

Market Cap: US$4.5b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

Hikma Pharmaceuticals

Market Cap: UK£3.3b

Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.

Merit Medical Systems

Market Cap: US$4.4b

Designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally.

Relay Therapeutics

Market Cap: US$4.4b

Operates as a clinical-stage precision medicines company.

Waystar Holding

Market Cap: US$4.3b

Develops a cloud-based software solution for healthcare payments.

MiniMed Group

Market Cap: US$4.3b

Operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes.

Envista Holdings

Market Cap: US$4.2b

Develops, manufactures, markets, and sells dental products in the United States, China, and internationally.